nursing exam 1

Week One

  1. Definitions:

    • Pharmacology: The scientific study of drugs, including their composition, effects, and interactions with living organisms.

    • Therapeutics: The branch of medicine concerned with the treatment of diseases and the practice of medicine.

    • Pharmacotherapy: The use of drugs to treat or manage disease, focusing on the application of pharmacological principles to clinical practice.

  2. Classifications of Therapeutic Agents:

    • Prescription Drugs: Medications that require a doctor’s prescription due to their potential risks and complexities in use.

    • Over-the-Counter (OTC) Drugs: Medications available without a prescription, generally considered safe for use without professional supervision.

    • Herbal Remedies: Natural products derived from plants used for therapeutic purposes.

    • Dietary Supplements: Products taken orally that contain dietary ingredients intended to supplement the diet (e.g., vitamins, minerals).

  3. Drug Classifications:

    • Therapeutic Classification: Based on the therapeutic effect of the drug (e.g., antihypertensives for lowering blood pressure).

    • Pharmacologic Classification: Based on the drug’s mechanism of action or its effect on the body’s systems (e.g., beta-blockers affecting heart rate).

    • Over-the-Counter (OTC): Medications available without a prescription, used for minor health issues.

    • Prescription: Medications requiring a healthcare provider’s prescription due to their potential for misuse or serious side effects.

    • Prototype: A well-understood drug that serves as a standard for comparison within a drug class (e.g., morphine as a prototype opioid).

  4. Pharmacokinetic Terms:

    • Bioavailability: The fraction of an administered dose of a drug that reaches the systemic circulation in an active form.

    • Half-life: The time required for the concentration of a drug in the bloodstream to decrease by half.

    • Onset of Action: The time it takes for a drug to start producing its effects after administration.

    • Therapeutic Range: The plasma drug concentration range between the minimum effective concentration and the minimum toxic concentration.

    • Peak: The highest concentration of a drug in the blood after administration.

    • Duration: The length of time that a drug’s therapeutic effect lasts.

    • Toxic Level: The concentration of a drug at which it causes adverse or harmful effects.

  5. Pharmacoeconomic vs. Risk-Benefit Ratio:

    • Pharmacoeconomic: Evaluates the cost-effectiveness of drugs, considering factors like cost per benefit, cost of treatment versus benefit, and overall economic impact.

    • Risk-Benefit Ratio: Assesses the advantages of a drug in treating a condition against the risks and potential side effects of the drug.

  6. Definitions:

    • Prescriptive Authority: The legal right and responsibility of healthcare providers to prescribe medications.

    • Dependence: A condition where a person develops a physical or psychological reliance on a drug, often requiring it to function normally.

    • Withdrawal: Symptoms experienced when a person stops using a drug they are dependent on.

    • Controlled Substances and Drug Schedules: Classification of drugs into schedules (I-V) based on their potential for abuse and medical use. Schedule I drugs have the highest potential for abuse and no accepted medical use (e.g., heroin), while Schedule V drugs have the lowest potential for abuse (e.g., some cough preparations).

    • Teratogenic Risk and Pregnancy Risk Categories: The risk a drug poses to fetal development. Categories range from A (no risk) to X (contraindicated in pregnancy).

  7. Principles of Drug Administration:

    • Correct Drug: Verify the medication to ensure it is the right one for the patient.

    • Correct Dose: Ensure the dose is accurate and appropriate for the patient’s condition.

    • Correct Route: Administer the drug via the proper route (oral, IV, etc.).

    • Correct Time: Administer the drug at the prescribed time intervals.

    • Correct Patient: Verify patient identity to prevent medication errors.

  8. Routes of Drug Administration:

    • Enteral: Drugs are absorbed through the digestive tract. Common routes include oral (by mouth) and rectal (through the rectum).

    • Parenteral: Drugs are administered through routes other than the digestive tract, typically by injection (e.g., intravenous, intramuscular).

    • Topical: Drugs are applied directly to a specific area of the skin or mucous membranes (e.g., creams, patches).

  9. Five Rights of Drug Administration:

    • Right Drug: The medication administered should be the one prescribed.

    • Right Dose: The amount of medication administered should be accurate.

    • Right Route: The method of administration should be as prescribed.

    • Right Time: Medication should be administered at the correct time and frequency.

    • Right Patient: The medication should be given to the correct patient.

  10. Active Transport vs. Diffusion:

    • Active Transport: Requires energy (usually ATP) to move substances against their concentration gradient (e.g., sodium-potassium pump).

    • Diffusion: A passive process where substances move from an area of higher concentration to an area of lower concentration without energy expenditure (e.g., oxygen entering cells).

  11. Pharmacokinetic Processes:

    • Absorption: The process by which a drug enters the bloodstream from the site of administration. Involves the gastrointestinal system for oral drugs and blood vessels for injections.

    • Distribution: The dispersion or spreading of substances throughout the fluids and tissues of the body. Mainly involves the circulatory system.

    • Metabolism: The chemical modification made by an organism on a chemical compound. Primarily occurs in the liver.

    • Excretion: The process of removing drugs and metabolites from the body, mainly via the kidneys through urine.

  12. Loading Dose vs. Maintenance Dose:

    • Loading Dose: A higher initial dose of a drug given to rapidly achieve therapeutic levels in the bloodstream.

    • Maintenance Dose: The dose required to keep the drug concentration within the therapeutic range after the loading dose has been administered.

  13. Therapeutic Index:

    • Answer: The ratio of the toxic dose to the therapeutic dose of a drug. A higher therapeutic index indicates a wider margin of safety between the effective and toxic doses.

  14. Definitions:

    • Pharmacodynamics: The study of how drugs interact with cellular receptors and the subsequent effects on the body.

    • Antagonist: A substance that binds to a receptor and blocks or inhibits a response.

    • Partial Agonist: A drug that activates a receptor but produces a sub-maximal effect compared to a full agonist.

    • Agonist: A substance that binds to a receptor and activates it, producing a physiological response.

Week Two

  1. Nursing Process Steps:

    • Assessment: Collecting and analyzing patient data to identify health needs.

    • Diagnosis: Formulating clinical judgments based on the assessment data.

    • Planning: Developing a plan of care with specific goals and interventions.

    • Implementation: Executing the care plan and interventions.

    • Evaluation: Assessing the effectiveness of the care plan and making adjustments as needed.

  2. Types of Assessment Data:

    • Subjective Data: Information provided by the patient, including symptoms and personal experiences (e.g., pain levels, feelings of nausea).

    • Objective Data: Observable and measurable data collected through physical examination, laboratory tests, and diagnostic imaging (e.g., blood pressure readings, lab results).

  3. Patient/Medical History Components:

    • Personal Information: Name, age, gender, and contact details.

    • Medical History: Previous illnesses, surgeries, hospitalizations, and current medical conditions.

    • Medications: Current and past medications, including dosages and duration.

    • Allergies: Known allergies to medications, foods, or other substances.

    • Family History: Health conditions of family members that might affect the patient’s health.

    • Social History: Lifestyle factors, including smoking, alcohol use, occupation, and living conditions.

  4. Nursing vs. Medical Diagnoses:

    • Nursing Diagnosis: Focuses on patient responses to health conditions or life processes and is used to guide nursing interventions (e.g., impaired mobility).

    • Medical Diagnosis: Identifies the specific disease or condition affecting the patient and guides medical treatment (e.g., diabetes mellitus).

  5. Planning Step Components:

    • Goals: Specific, measurable objectives the patient aims to achieve (e.g., reducing blood glucose levels to a target range).

    • Interventions: Specific actions or treatments to achieve the goals (e.g., administering insulin, providing dietary counseling).

    • Outcomes: Expected results of the interventions, used to evaluate the effectiveness of the care plan.

  6. Implementation and Evaluation:

    • Implementation: Carrying out the planned interventions, including administering medications, performing procedures, and providing patient education.

    • Evaluation: Reviewing the patient’s progress toward the goals and assessing whether the interventions were effective, making necessary adjustments to the care plan.

  7. Medication Error Factors:

    • Common Errors: Incorrect dosages, wrong medication, improper administration techniques, and lack of patient information.

    • Prevention: Double-checking orders, using technology (e.g., electronic medication administration records), and clear communication among healthcare providers.

  8. Limitation in Medication Error Data:

    • Answer: Incomplete reporting and underreporting of medication errors, which hinders accurate data collection and analysis.

  9. Strategies for Reducing Errors:

    • Standardization: Implementing protocols and checklists to reduce variability and errors.

    • Education: Providing ongoing training and education for healthcare providers on safe medication practices.

    • Technology: Utilizing electronic health records and barcoding systems to minimize human errors.

  10. Medication Management in Pregnant/Lactating Patients:

    • Considerations: Assessing the risk of medications to the developing fetus or breastfeeding infant, and using drugs that are known to be safe during pregnancy and lactation.

  11. Placental Effects:

    • Answer: The placenta can act as a barrier but also allows for the transfer of drugs from the mother to the fetus, affecting drug levels and potential effects on fetal development.

  12. Pregnancy Gestation Periods:

    • First Trimester: Critical for organ formation and development. Greatest risk for teratogenic effects from drugs.

    • Second Trimester: Period of growth and further development; drugs can affect growth and development.

    • Third Trimester: Fetal growth continues; drugs can impact birth weight and neonatal health.

  13. Medication Categorization in Pregnancy:

    • Categories:

      • Category A: No risk to the fetus in any trimester.

      • Category B: No evidence of risk in humans; animal studies may show risk.

      • Category C: Risk cannot be ruled out; benefits may outweigh risks.

      • Category D: Positive evidence of risk; benefits may outweigh risks in serious conditions.

      • Category X: Contraindicated in pregnancy; risks outweigh benefits.

  14. Developmental Factors in Pediatrics:

    • Age-Specific Considerations: Dosing adjustments based on weight, age, and developmental stage. Pediatric patients metabolize drugs differently compared to adults.

  15. Pharmacokinetic Variations:

    • Pediatric: Increased metabolic rate; dosing adjustments required.

    • Pregnant: Altered drug metabolism and clearance; increased dosing may be necessary.

    • Older Adults: Decreased metabolism and renal function; increased risk of adverse effects and need for dose adjustments.

  16. Holistic Pharmacotherapy Considerations:

    • Comprehensive Approach: Integrates the patient’s physical, emotional, and social well-being into treatment plans, considering their lifestyle and preferences.

  17. Ethnicity vs. Culture:

    • Ethnicity: Refers to shared ancestry and genetic traits among a group of people.

    • Culture: Refers to shared beliefs, practices, and values, which influence health behaviors and attitudes.

  18. Pharmacogenetics:

    • Answer: The study of how genetic variations affect individual responses to drugs, including efficacy and risk of adverse effects.

  19. Genetic Polymorphism:

    • Answer: Variations in genes that lead to different enzymatic activities affecting drug metabolism, such as variations in CYP450 enzymes.

Week Three

  1. Complementary, Alternative, Integrative Medicine:

    • Complementary: Used alongside conventional medicine (e.g., acupuncture for pain relief).

    • Alternative: Used instead of conventional medicine (e.g., herbal remedies for treating colds).

    • Integrative: Combines conventional and complementary approaches to enhance overall care (e.g., combining yoga with physical therapy).

  2. Natural Products and Mind/Body Practices:

    • Natural Products: Includes herbs (e.g., echinacea), vitamins (e.g., vitamin C), and minerals (e.g., magnesium).

    • Mind/Body Practices: Techniques aimed at improving mental and physical health (e.g., mindfulness meditation, tai chi).

  3. Homeopathy vs. Naturopathy:

    • Homeopathy: Uses extremely diluted substances to stimulate the body’s healing processes based on the principle of "like cures like."

    • Naturopathy: Emphasizes natural remedies and lifestyle changes to support the body’s ability to heal itself, incorporating various treatments including herbal medicine, nutrition, and physical therapies.

  4. Regulatory Bodies:

    • Medications: Regulated by the FDA (Food and Drug Administration) with rigorous testing and approval processes.

    • Supplements/Herbal Products: Regulated less strictly by the FDA; less evidence is required for efficacy and safety, leading to variable quality and efficacy.

  5. Asking About Supplements:

    • Rationale: To identify potential interactions with prescribed medications, assess overall health practices, and ensure the patient’s safety.

  6. Definitions:

    • Epidemic: An outbreak of a disease affecting many individuals in a community or population.

    • Pandemic: An epidemic that spreads across multiple countries or continents.

    • Bioterrorism: The intentional release of viruses, bacteria, or other pathogens to cause harm and spread fear.

  7. Nursing Actions in Infection Control:

    • Actions: Proper hand hygiene, use of personal protective equipment (PPE), adherence to infection control protocols, and vaccination.

  8. Agents Used in Bioterrorism:

    • Examples: Anthrax (bacterial), smallpox (viral), ricin (toxin).

  9. Medical Management of Poisonings:

    • Prioritization: Immediate assessment, stabilization of the patient, and administration of appropriate antidotes or treatments.

  10. Antidotes for Poisonings:

    • Warfarin: Vitamin K.

    • Acetylcysteine: Acetaminophen toxicity.

    • Donepezil: Atropine (for cholinergic crisis).

    • Lead Poisoning: Chelating agents like EDTA.

    • Oxycodone: Naloxone (opioid antagonist).